Quarterly report pursuant to sections 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (UNAUDITED)

v2.4.0.8
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (UNAUDITED) (USD $)
Common Stock
Additional Paid-in Capital
Deficit Accumulated During the Development Stage
Total
Beginning Balance, Amount at Dec. 31, 2013 $ 176,243 $ 95,937,936 $ (93,038,863) $ 3,075,316
Beginning Balance, Shares at Dec. 31, 2013 176,242,817      
Common stock issued upon exercise of warrants and options, net Amount 4,361 1,303,923   1,308,284
Common stock issued upon exercise of warrants and options, net Shares 4,360,947      
Fair value of options and warrants issued as compensation   155,378   155,378
Net loss     (1,403,474) (1,403,474)
Ending Balance, Amount at Mar. 31, 2014 $ 180,604 $ 97,397,237 $ (94,442,337) $ 3,135,504
Ending Balance, Shares at Mar. 31, 2014 180,603,764